Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25754297 | 0.94 | TSHR (0.33) | TSHR | |
| SCHEMBL25754292 | 0.87 | TSHR (0.33) | TSHR | |
| SCHEMBL25754295 | 0.85 | TSHR (0.35) | TSHR | |
| SCHEMBL241373 | 0.80 | TSHR (0.40) | TSHRKDM4ERECQL | |
| SCHEMBL25754281 | 0.78 | CA12 (0.31) | TSHRRECQL | |
| SCHEMBL5932102 | 0.78 | TSHR (0.43) | TSHRKDM4ERECQL | |
| SCHEMBL10959162 | 0.78 | TSHR (0.43) | TSHRKDM4ERECQL | |
| SCHEMBL25754301 | 0.76 | KDM4E (0.38) | TSHRKDM4E | |
| SCHEMBL15788000 | 0.75 | TSHR (0.38) | TSHRKDM4ERECQL | |
| SCHEMBL25754276 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230210999-A1 | TARGETED PROTEASE DEGRADATION (TED) PLATFORM | EUBULUS BIOTHERAPEUTICS (HONG KONG) LIMITED (HK) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230210999-A1 | TARGETED PROTEASE DEGRADATION (TED) PLATFORM | UCHL3, UBE2L3, ADAM33 | TSHR 331/4885KDM4E 2658/4885RECQL 1284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.